Migraine Drugs Market: Global Trends, Share, Size, Growth, Opportunity and Forecast 2018-2026

A migraine is more than just a throbbing headache. This neurological condition causes excruciating throbbing pain that can keep you in bed for days! Pain, weariness, nausea, visual problems, numbness and tingling, irritation, difficulty speaking, temporary loss of eyesight, and other symptoms may be caused by movement, light, sound, and other stimuli.

                      Migraine Drugs Market



A migraine is more than just a throbbing headache. This neurological condition causes excruciating throbbing pain that can keep you in bed for days! Pain, weariness, nausea, visual problems, numbness and tingling, irritation, difficulty speaking, temporary loss of eyesight, and other symptoms may be caused by movement, light, sound, and other stimuli.


One of the primary reasons driving market expansion is a significant increase in the prevalence and diagnosis of migraine. Aside from that, the migraine drugs market is growing due to improvements in reimbursement policies for migraine treatments, as well as the rising demand for precision medicines. Additionally, rising demand for electrical nerve stimulating devices to treat migraines, as well as the expected approval of new classes of late-stage pipeline drugs with higher clinical efficacy, such as the introduction of calcitonin gene-related peptide (CGRP) monoclonal antibodies, are propelling market growth.


Market Segmentation:

By Drugs Type:
  • Ergotamine
  • Triptans
  • Nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Others

By Route of Administration:
  • Oral
  • Parenteral

By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

In the projected term, the introduction of new pharmaceuticals to the market is expected to drive the migraine drugs market. For example, on June 20, 2017, the Food and Drug Administration (FDA) gave final approval to the Indian pharmaceutical company Cadila Healthcare Ltd. (Zydus Cadila) to market Eletriptan Hydrobromide tablets (20 mg and 40 mg), which is used to treat migraines.


There are various players across the globe running into the competition includes Endo International plc, Pfizer Inc., Aegis Therapeutics, LLC., Aeriel BioPharma, Alder BioPharmaceuticals Inc., Amgen Inc., Astellas Pharma Inc., CoLucid Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., IntelGenx Corp., Johnson & Johnson, Kowa Pharmaceuticals America, Luitpold Pharmaceuticals, Teva Pharmaceutical Industries LTD., Valeant Pharmaceuticals International, Inc., WINSTON PHARMACEUTICALS, Inc., Zogenix Inc., Abbott Laboratories, AstraZeneca plc, and GlaxoSmithKline plc.

Comments

Post a Comment

Popular posts from this blog

Flavors and Fragrances Market: A Comprehensive Analysis of Current Trends and Future Outlook

Image
  Flavors and Fragrances Market Introduction: The global flavors and fragrances market has witnessed remarkable growth in recent years, driven by increasing consumer preferences for enhanced sensory experiences in various industries. Flavors and fragrances play a vital role in food and beverages, personal care products, household products, and the pharmaceutical industry. This report provides an in-depth analysis of the flavors and fragrances market, highlighting key trends, market dynamics, and future prospects. Market Overview: The flavors and fragrances market has experienced substantial growth, with a projected CAGR of X% from 2023 to 2028. The market is primarily driven by rising disposable incomes, urbanization, and changing consumer lifestyles. Key market players are continually investing in research and development activities to introduce innovative flavors and fragrances that cater to evolving consumer demands. Segmentation and Key Market Players: The market can...
Read more

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the...
Read more

Global Orthopedic Imaging Market Size By Product, By Indication, By End User, Analysis And Forecast 2027

Image
                              Orthopedic Imaging Market Medical imaging in orthopaedics allows doctors to examine the interior architecture of the body non-invasively to aid in the diagnosis of a medical disease. Medical imaging technologies detect and track illnesses and injuries by providing pictures that represent the interior anatomical features of the patient's body. These gadgets are utilised as a knowledge tool to assist clinicians in determining the condition and its response to therapy. Orthopedic medical imaging provides clinicians with dependable, accessible, and high-quality imaging, which is an important criterion for medical decision-making and may lessen the need for surgical operations. Increased incidences of bone fracture trauma due to falls, motor vehicle accidents, or sports injuries necessitate prompt medical attention, which orthopaedic medical imaging systems may deliver. According to the ...
Read more